Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Notes Payables (2019 - 2021)

Silo Pharma (SILO) has disclosed Notes Payables for 3 consecutive years, with $18900.0 as the latest value for Q3 2021.

  • Quarterly Notes Payables rose 160.4% to $18900.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $18900.0 through Sep 2021, up 160.4% year-over-year, with the annual reading at $14654.0 for FY2020, 76.32% down from the prior year.
  • Notes Payables hit $18900.0 in Q3 2021 for Silo Pharma, roughly flat from $18900.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $144375.0 in Q1 2020 to a low of $7258.0 in Q2 2020.
  • Historically, Notes Payables has averaged $35117.4 across 3 years, with a median of $18900.0 in 2021.
  • Biggest YoY gain for Notes Payables was 160.4% in 2021; the steepest drop was 87.65% in 2021.
  • Year by year, Notes Payables stood at $61875.0 in 2019, then tumbled by 76.32% to $14654.0 in 2020, then grew by 28.98% to $18900.0 in 2021.
  • Business Quant data shows Notes Payables for SILO at $18900.0 in Q3 2021, $18900.0 in Q2 2021, and $17837.0 in Q1 2021.